Phase I study to assess safety, biodistribution and radiation dosimetry for Zr-89-girentuximab in patients with renal cell carcinoma

Merkx, RIJ; Lobeek, D; Konijnenberg, M; Jimenez-Franco, LD; Kluge, A; Oosterwijk, E; Mulders, PFA; Rijpkema, M

Merkx, RIJ (corresponding author), Radboudumc, Dept Med Imaging Nucl Med, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands.; Merkx, RIJ (corresponding author), Radboudumc, Dept Urol, Nijmegen, Netherlands.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021; 48 (10): 3277

Abstract

Purpose In this phase I study, we evaluated the safety, biodistribution and dosimetry of [Zr-89]Zr-DFO-girentuximab (Zr-89-girentuximab) PET/CT imagin......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索